234 related articles for article (PubMed ID: 17125716)
1. [Menopausal hormone therapy and cardiovascular disease].
Wenger NK
Rev Esp Cardiol; 2006 Oct; 59(10):1058-69. PubMed ID: 17125716
[TBL] [Abstract][Full Text] [Related]
2. [The current state of hormonal prevention of coronary heart disease in menopausal women].
Wenger NK
Rev Esp Cardiol; 2003 Jan; 56(1):1-8. PubMed ID: 12549992
[TBL] [Abstract][Full Text] [Related]
3. Baseline characteristics of menopausal women with coronary heart disease in cardiovascular outcomes clinical trials of menopausal hormone therapy or raloxifene.
Wenger NK; Geiger MJ
Contemp Clin Trials; 2005 Dec; 26(6):612-5. PubMed ID: 16257585
[TBL] [Abstract][Full Text] [Related]
4. Comparative cardiovascular effects of different progestins in menopause.
Rosano GM; Fini M
Int J Fertil Womens Med; 2001; 46(5):248-56. PubMed ID: 11720197
[TBL] [Abstract][Full Text] [Related]
5. Menopausal hormone therapy and cardiovascular protection: state of the data 2003.
Wenger NK
J Am Med Womens Assoc (1972); 2003; 58(4):236-9. PubMed ID: 14640254
[TBL] [Abstract][Full Text] [Related]
6. Timing and duration of menopausal hormone treatment may affect cardiovascular outcomes.
Harman SM; Vittinghoff E; Brinton EA; Budoff MJ; Cedars MI; Lobo RA; Merriam GR; Miller VM; Naftolin F; Pal L; Santoro N; Taylor HS; Black DM
Am J Med; 2011 Mar; 124(3):199-205. PubMed ID: 21396500
[TBL] [Abstract][Full Text] [Related]
7. [Hormone replacement therapy and cardiovascular prevention. Where are we now?].
Lerman J; Siseles N
Medicina (B Aires); 2008; 68(3):251-7. PubMed ID: 18689159
[TBL] [Abstract][Full Text] [Related]
8. The evolving role of oral hormonal therapies and review of conjugated estrogens/bazedoxifene for the management of menopausal symptoms.
Parish SJ; Gillespie JA
Postgrad Med; 2017 Apr; 129(3):340-351. PubMed ID: 28132583
[TBL] [Abstract][Full Text] [Related]
9. Hormone replacement therapy trials: an update.
Duvernoy CS; Mosca L
Curr Atheroscler Rep; 2002 Mar; 4(2):156-60. PubMed ID: 11822980
[TBL] [Abstract][Full Text] [Related]
10. [Indications for hormone replacement therapy].
Birkhäuser MH
Ther Umsch; 2000 Oct; 57(10):635-42. PubMed ID: 11081375
[TBL] [Abstract][Full Text] [Related]
11. Rationale and overview of the Raloxifene Use for the Heart (RUTH) trial.
Mosca L
Ann N Y Acad Sci; 2001 Dec; 949():181-5. PubMed ID: 11795352
[TBL] [Abstract][Full Text] [Related]
12. Raloxifene and cardiovascular events in osteoporotic postmenopausal women: four-year results from the MORE (Multiple Outcomes of Raloxifene Evaluation) randomized trial.
Barrett-Connor E; Grady D; Sashegyi A; Anderson PW; Cox DA; Hoszowski K; Rautaharju P; Harper KD;
JAMA; 2002 Feb; 287(7):847-57. PubMed ID: 11851576
[TBL] [Abstract][Full Text] [Related]
13. Design and methods of the Raloxifene Use for The Heart (RUTH) study.
Mosca L; Barrett-Connor E; Wenger NK; Collins P; Grady D; Kornitzer M; Moscarelli E; Paul S; Wright TJ; Helterbrand JD; Anderson PW
Am J Cardiol; 2001 Aug; 88(4):392-5. PubMed ID: 11545760
[TBL] [Abstract][Full Text] [Related]
14. [The benefits and risks of hormonal replacement therapy--an update].
Schmidt M; Kimmig R
Gynakol Geburtshilfliche Rundsch; 2006; 46(4):166-73. PubMed ID: 17068401
[TBL] [Abstract][Full Text] [Related]
15. Biological significance of interventions that change breast density.
Chlebowski RT; McTiernan A
J Natl Cancer Inst; 2003 Jan; 95(1):4-5. PubMed ID: 12509389
[No Abstract] [Full Text] [Related]
16. KEEPS: The Kronos Early Estrogen Prevention Study.
Harman SM; Brinton EA; Cedars M; Lobo R; Manson JE; Merriam GR; Miller VM; Naftolin F; Santoro N
Climacteric; 2005 Mar; 8(1):3-12. PubMed ID: 15804727
[TBL] [Abstract][Full Text] [Related]
17. Post-menopausal hormone replacement therapy (cont'd): risk-benefit balance in the hot seat.
Prescrire Int; 2004 Jun; 13(71):106-9. PubMed ID: 15233153
[TBL] [Abstract][Full Text] [Related]
18. Hormone replacement therapy (HRT) and ischaemic heart disease: getting to the heart of the matter.
Chew S; Ng SC
Singapore Med J; 2002 Jan; 43(1):41-4. PubMed ID: 12008777
[TBL] [Abstract][Full Text] [Related]
19. [Hormone replacement therapy and cardiovascular risk].
Maffei S; De Caterina R
G Ital Cardiol; 1996 Aug; 26(8):899-940. PubMed ID: 9005173
[TBL] [Abstract][Full Text] [Related]
20. [Hormonal replacement therapy and selective estrogen receptor modulators in prevention of cardiovascular disease].
Kozakiewicz K; Wycisk A
Wiad Lek; 2006; 59(5-6):377-82. PubMed ID: 17017486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
